APO Research
Talk to an analyst

APO RESEARCH · REPORT

Respiratory Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Respiratory Drugs Industry Growth and Trends Forecast to 2032

22 December 202591 pages

Choose your research edition.

Industry ResearchRespiratory Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Respiratory Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Respiratory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Respiratory Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Respiratory Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Respiratory Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Respiratory Drugs include Abbott, Pfizer, Amgen, Amgen, Horizon Pharma, FibroGen, Dr. Reddy's Laboratories, Dainippon Sumitomo and Afferent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Respiratory Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Respiratory Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Respiratory Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Respiratory Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Respiratory Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Respiratory Drugs Market by Company

Abbott

Pfizer

Amgen

Amgen

Horizon Pharma

FibroGen

Dr. Reddy's Laboratories

Dainippon Sumitomo

Afferent Pharmaceuticals

Respiratory Drugs Segment by Type

Asthma

Idiopathic Pulmonary Fibrosis

Cystic Fibrosis

Chronic Obstructive Pulmonary Disease

Respiratory Drugs Segment by Application

Ambulatory Care

Hospitals

Others

Respiratory Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Respiratory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Respiratory Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Respiratory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Asthma Table 2. Major Company of Idiopathic Pulmonary Fibrosis Table 3. Major Company of Cystic Fibrosis Table 4. Major Company of Chronic Obstructive Pulmonary Disease Table 5. Global Respiratory Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 7. Global Respiratory Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Respiratory Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Respiratory Drugs Price by Type (2021-2026) & (US$/unit) Table 11. Global Respiratory Drugs Sales by Type (2027-2032) & (k units) Table 12. Global Respiratory Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Respiratory Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Respiratory Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Respiratory Drugs Price by Type (2027-2032) & (US$/unit) Table 16. North America Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 17. North America Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 19. Europe Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 23. Latin America Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Respiratory Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Respiratory Drugs Industry Trends Table 27. Respiratory Drugs Industry Drivers Table 28. Respiratory Drugs Industry Opportunities and Challenges Table 29. Respiratory Drugs Industry Restraints Table 30. Global Respiratory Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Respiratory Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Respiratory Drugs Sales by Company (2021-2026) & (k units) Table 33. Global Respiratory Drugs Sales Share by Company (2021-2026) Table 34. Global Respiratory Drugs Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Respiratory Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Respiratory Drugs Major Company Production Sites and Headquarters Table 37. Global Respiratory Drugs Company, Product Type & Application Table 38. Global Respiratory Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Respiratory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Respiratory Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Respiratory Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Respiratory Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Respiratory Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Respiratory Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Respiratory Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Respiratory Drugs Sales by Region (2027-2032) & (k units) Table 48. Global Respiratory Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Respiratory Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Respiratory Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Respiratory Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Respiratory Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Respiratory Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Respiratory Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Respiratory Drugs Price by Application (2021-2026) & (US$/unit) Table 58. Global Respiratory Drugs Sales by Application (2027-2032) & (k units) Table 59. Global Respiratory Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Respiratory Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Respiratory Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Respiratory Drugs Price by Application (2027-2032) & (US$/unit) Table 63. North America Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 64. North America Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 66. Europe Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 70. Latin America Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Respiratory Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Abbott Company Information Table 74. Abbott Business Overview Table 75. Abbott Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Abbott Respiratory Drugs Product Portfolio Table 77. Abbott Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Pfizer Respiratory Drugs Product Portfolio Table 82. Pfizer Recent Development Table 83. Amgen Company Information Table 84. Amgen Business Overview Table 85. Amgen Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Amgen Respiratory Drugs Product Portfolio Table 87. Amgen Recent Development Table 88. Amgen Company Information Table 89. Amgen Business Overview Table 90. Amgen Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Amgen Respiratory Drugs Product Portfolio Table 92. Amgen Recent Development Table 93. Horizon Pharma Company Information Table 94. Horizon Pharma Business Overview Table 95. Horizon Pharma Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Horizon Pharma Respiratory Drugs Product Portfolio Table 97. Horizon Pharma Recent Development Table 98. FibroGen Company Information Table 99. FibroGen Business Overview Table 100. FibroGen Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. FibroGen Respiratory Drugs Product Portfolio Table 102. FibroGen Recent Development Table 103. Dr. Reddy's Laboratories Company Information Table 104. Dr. Reddy's Laboratories Business Overview Table 105. Dr. Reddy's Laboratories Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Dr. Reddy's Laboratories Respiratory Drugs Product Portfolio Table 107. Dr. Reddy's Laboratories Recent Development Table 108. Dainippon Sumitomo Company Information Table 109. Dainippon Sumitomo Business Overview Table 110. Dainippon Sumitomo Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Dainippon Sumitomo Respiratory Drugs Product Portfolio Table 112. Dainippon Sumitomo Recent Development Table 113. Afferent Pharmaceuticals Company Information Table 114. Afferent Pharmaceuticals Business Overview Table 115. Afferent Pharmaceuticals Respiratory Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Afferent Pharmaceuticals Respiratory Drugs Product Portfolio Table 117. Afferent Pharmaceuticals Recent Development Table 118. North America Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. North America Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 120. North America Respiratory Drugs Sales Market Share by Country (2021-2026) Table 121. North America Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 122. North America Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 123. North America Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Respiratory Drugs Market Share by Country (2021-2026) Table 126. North America Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 128. Europe Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Europe Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 130. Europe Respiratory Drugs Sales Market Share by Country (2021-2026) Table 131. Europe Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 132. Europe Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Respiratory Drugs Market Share by Country (2021-2026) Table 136. Europe Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 140. Asia-Pacific Respiratory Drugs Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 142. Asia-Pacific Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Respiratory Drugs Market Share by Country (2021-2026) Table 146. Asia-Pacific Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 148. Latin America Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Latin America Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 150. Latin America Respiratory Drugs Sales Market Share by Country (2021-2026) Table 151. Latin America Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 152. Latin America Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Respiratory Drugs Market Share by Country (2021-2026) Table 156. Latin America Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Respiratory Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 160. Middle East and Africa Respiratory Drugs Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Respiratory Drugs Sales Forecast by Country (2027-2032) & (k units) Table 162. Middle East and Africa Respiratory Drugs Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Respiratory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Respiratory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Respiratory Drugs Market Share by Country (2021-2026) Table 166. Middle East and Africa Respiratory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Respiratory Drugs Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Respiratory Drugs Distributors List Table 171. Respiratory Drugs Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Respiratory Drugs Image Figure 2. Global Respiratory Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Respiratory Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Respiratory Drugs Sales (2021-2032) & (k units) Figure 5. Asthma Image Figure 6. Global Asthma Sales YoY Growth (2021-2032) & (k units) Figure 7. Idiopathic Pulmonary Fibrosis Image Figure 8. Global Idiopathic Pulmonary Fibrosis Sales YoY Growth (2021-2032) & (k units) Figure 9. Cystic Fibrosis Image Figure 10. Global Cystic Fibrosis Sales YoY Growth (2021-2032) & (k units) Figure 11. Chronic Obstructive Pulmonary Disease Image Figure 12. Global Chronic Obstructive Pulmonary Disease Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Respiratory Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Respiratory Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Respiratory Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Respiratory Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Respiratory Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Ambulatory Care Image Figure 28. Global Ambulatory Care Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Respiratory Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Respiratory Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Respiratory Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Respiratory Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Respiratory Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Respiratory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Respiratory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Respiratory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Respiratory Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Respiratory Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Asthma
  • Idiopathic Pulmonary Fibrosis
  • Cystic Fibrosis
  • Chronic Obstructive Pulmonary Disease
Applications
  • Ambulatory Care
  • Hospitals
  • Others
Companies covered
  • Abbott
  • Pfizer
  • Amgen
  • Amgen
  • Horizon Pharma
  • FibroGen
  • Dr. Reddy's Laboratories
  • Dainippon Sumitomo
  • Afferent Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Respiratory Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Respiratory Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Respiratory Drugs Market by Type
  6. 1.3.1 Asthma
  7. 1.3.2 Idiopathic Pulmonary Fibrosis
  8. 1.3.3 Cystic Fibrosis
  9. 1.3.4 Chronic Obstructive Pulmonary Disease
  10. 1.4 Global Respiratory Drugs Market Size by Type
  11. 1.4.1 Global Respiratory Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Respiratory Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Respiratory Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Respiratory Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Respiratory Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Respiratory Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Respiratory Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Respiratory Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Respiratory Drugs Industry Trends
  2. 2.2 Respiratory Drugs Industry Drivers
  3. 2.3 Respiratory Drugs Industry Opportunities and Challenges
  4. 2.4 Respiratory Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Respiratory Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Respiratory Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Respiratory Drugs Price (2021-2026)
  4. 3.4 Global Respiratory Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Respiratory Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Respiratory Drugs Company, Product Type & Application
  7. 3.7 Global Respiratory Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Respiratory Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Respiratory Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Respiratory Drugs Tier 1, Tier 2, and Tier 3
4 Respiratory Drugs Regional Status and Outlook
  1. 4.1 Global Respiratory Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Respiratory Drugs Historic Market Size by Region
  3. 4.2.1 Global Respiratory Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Respiratory Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Respiratory Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Respiratory Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Respiratory Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Respiratory Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Respiratory Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Respiratory Drugs by Application
  1. 5.1 Respiratory Drugs Market by Application
  2. 5.1.1 Ambulatory Care
  3. 5.1.2 Hospitals
  4. 5.1.3 Others
  5. 5.2 Global Respiratory Drugs Market Size by Application
  6. 5.2.1 Global Respiratory Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Respiratory Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Respiratory Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Respiratory Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Respiratory Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Respiratory Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Respiratory Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Respiratory Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Respiratory Drugs Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Respiratory Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Respiratory Drugs Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Amgen
  20. 6.4.1 Amgen Company Information
  21. 6.4.2 Amgen Business Overview
  22. 6.4.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Amgen Respiratory Drugs Product Portfolio
  24. 6.4.5 Amgen Recent Developments
  25. 6.5 Horizon Pharma
  26. 6.5.1 Horizon Pharma Company Information
  27. 6.5.2 Horizon Pharma Business Overview
  28. 6.5.3 Horizon Pharma Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Horizon Pharma Respiratory Drugs Product Portfolio
  30. 6.5.5 Horizon Pharma Recent Developments
  31. 6.6 FibroGen
  32. 6.6.1 FibroGen Company Information
  33. 6.6.2 FibroGen Business Overview
  34. 6.6.3 FibroGen Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 FibroGen Respiratory Drugs Product Portfolio
  36. 6.6.5 FibroGen Recent Developments
  37. 6.7 Dr. Reddy's Laboratories
  38. 6.7.1 Dr. Reddy's Laboratories Company Information
  39. 6.7.2 Dr. Reddy's Laboratories Business Overview
  40. 6.7.3 Dr. Reddy's Laboratories Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Dr. Reddy's Laboratories Respiratory Drugs Product Portfolio
  42. 6.7.5 Dr. Reddy's Laboratories Recent Developments
  43. 6.8 Dainippon Sumitomo
  44. 6.8.1 Dainippon Sumitomo Company Information
  45. 6.8.2 Dainippon Sumitomo Business Overview
  46. 6.8.3 Dainippon Sumitomo Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Dainippon Sumitomo Respiratory Drugs Product Portfolio
  48. 6.8.5 Dainippon Sumitomo Recent Developments
  49. 6.9 Afferent Pharmaceuticals
  50. 6.9.1 Afferent Pharmaceuticals Company Information
  51. 6.9.2 Afferent Pharmaceuticals Business Overview
  52. 6.9.3 Afferent Pharmaceuticals Respiratory Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Afferent Pharmaceuticals Respiratory Drugs Product Portfolio
  54. 6.9.5 Afferent Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Respiratory Drugs Sales by Country
  2. 7.1.1 North America Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Respiratory Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Respiratory Drugs Market Size by Country
  6. 7.2.1 North America Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Respiratory Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Respiratory Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Respiratory Drugs Sales by Country
  2. 8.1.1 Europe Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Respiratory Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Respiratory Drugs Market Size by Country
  6. 8.2.1 Europe Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Respiratory Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Respiratory Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Respiratory Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Respiratory Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Respiratory Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Respiratory Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Respiratory Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Respiratory Drugs Sales by Country
  2. 10.1.1 South America Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Respiratory Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Respiratory Drugs Market Size by Country
  6. 10.2.1 South America Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Respiratory Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Respiratory Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Respiratory Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Respiratory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Respiratory Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Respiratory Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Respiratory Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Respiratory Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Respiratory Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Respiratory Drugs Value Chain Analysis
  2. 12.1.1 Respiratory Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Respiratory Drugs Production Mode & Process
  7. 12.2 Respiratory Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Respiratory Drugs Distributors
  10. 12.2.3 Respiratory Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst